Active Ingredient: FLUDEOXYGLUCOSE F-18
Proprietary Name: FLUDEOXYGLUCOSE F18
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: 20-300mCi/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A203603
Product Number: 001
Approval Date: Nov 13, 2015
Applicant Holder Full Name: CARDINAL HEALTH 414 LLC CARDINAL HEALTH NUCLEAR PHARMACY SERVICES
Marketing Status:
Prescription
Patent and Exclusivity Information